COVID-19 FHIR Profile Library IG
0.13.0 - 1st Comment Ballot

This page is part of the Logica COVID-19 FHIR Profile Library IG (v0.13.0: Drafts Ballot 1) based on FHIR R4. The current version which supercedes this version is 1.0.0. For a full list of available versions, see the Directory of published versions

Table of Contents

..0 Table of Contents
...1 Home
...2 Logica Comparison to E ICR
...3 Patient Demographics and Vital Signs
...4 Case Reporting Info
...5 Exposure Info
...6 Signs Symptoms Diagnoses Comorbidities
...7 Lab Profiles
...8 Smoking Status Pregnancy Status
...9 Exposure Questionnaire
...10 COVID 19 Immunization
...11 Downloads
...12 History
...13 Artifacts Summary
....13.1 COVID 19 Exposure Core profile
....13.2 Coded Laboratory Observation Base
....13.3 Laboratory Observation Base
....13.4 Laboratory Observation Panel Base
....13.5 Quantitative Laboratory Observation Base
....13.6 UnderlyingConditionObservationParent
....13.7 COVID 19 Exposure Questionnaire
....13.8 COVID-19 gastrointestinal and hepatic underlying condition
....13.9 COVID-19 hemoglobinopathy underlying condition
....13.10 COVID-19 ICD 10 Diagnosis
....13.11 COVID-19 immune underlying condition
....13.12 COVID-19 Immunization
....13.13 COVID 19 Vaccine Manufacturer
....13.14 COVID-19 renal underlying condition
....13.15 COVID-19 respiratory underlying condition
....13.16 COVID-19 SNOMED Diagnosis
....13.17 COVID 19 Symptoms Absent
....13.18 COVID 19 Symptoms Present
....13.19 COVID-19 uncategorized underlying condition
....13.20 COVID-19 cardiovascular underlying condition
....13.21 COVID-19 Underlying Medical Condition observation
....13.22 COVID-19 immunocompromised underlying condition
....13.23 COVID-19 General Underlying Conditions Absent
....13.24 COVID-19 General Underlying Conditions Present
....13.25 COVID-19 metabolic underlying condition
....13.26 COVID-19 neurologic underlying condition
....13.27 Case-Patient Report Identifying Information
....13.28 Exposure Type
....13.29 Influenza virus A and B RNA and SARS-CoV-2 (COVID-19) N gene panel - Respiratory specimen by NAA with probe detection
....13.30 Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection
....13.31 Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
....13.32 Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection
....13.33 Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay
....13.34 Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection
....13.35 Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection
....13.36 Gamma interferon background [Units/volume] in Blood by Immunoassay
....13.37 Gestational Age at Onset of Illness
....13.38 Human coronavirus 229E+HKU1+OC43+NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....13.39 Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection
....13.40 Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....13.41 Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....13.42 Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection
....13.43 Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay
....13.44 Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay
....13.45 Known Exposure
....13.46 Mitogen stimulated gamma interferon [Units/volume] corrected for background in Blood
....13.47 Mitogen stimulated gamma interferon [Units/volume] in Blood
....13.48 Pregnancy Status
....13.49 Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection
....13.50 SARS-CoV-2 (COVID19) IgG Ab [Presence] in DBS by Immunoassay
....13.51 SARS-CoV-2 (COVID19) Ab [Units/volume] in Serum or Plasma by Immunoassay
....13.52 SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum, Plasma, or Blood by Rapid imunoassay
....13.53 SARS-CoV-2 (COVID19) IgA + IgM [Presence] in Serum or Plasma by Immunoassay
....13.54 SARS-CoV-2 (COVID19) Ab [Presence] in Serum or Plasma by Immunoassay
....13.55 SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
....13.56 SARS-CoV-2 (COVID19) E gene [Presence] in Respiratory specimen by NAA with probe detection
....13.57 SARS-CoV-2 (COVID19) E gene [Presence] in Serum or Plasma by NAA with probe detection
....13.58 SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection
....13.59 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1
....13.60 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by Nucleaic acid amplification using CDC primer-probe set N2
....13.61 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1
....13.62 SARS-CoV-2 (COVID19) N gene [Presence] in Serum or Plasma by NAA with probe detection
....13.63 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1
....13.64 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2
....13.65 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N1
....13.66 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using primer-probe set N2
....13.67 SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection
....13.68 SARS-CoV-2 (COVID19) [Presence] in Unspecified specimen by Organism specific culture
....13.69 SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Respiratory specimen by NAA with probe detection
....13.70 SARS-CoV-2 (COVID19) RNA [Log#/volume] (viral load) in Unspecified specimen by NAA with probe detection
....13.71 SARS-Cov-2 (COVID19) RNA panel - Unspecified specimen by NAA with probe detection
....13.72 Sars-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with probe detection
....13.73 SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by NAA with probe
....13.74 SARS-CoV-2 (COVID19) RNA [Presence] in Saliva (oral fluid) by Sequencing
....13.75 SARS-CoV-2 (COVID19) RNA [Cycle Threshold#] in Unspecified specimen by NAA with probe detection
....13.76 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection
....13.77 SARS-CoV-2 (COVID19) S gene [Presence] in Serum or Plasma by NAA with probe detection
....13.78 SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection
....13.79 SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing
....13.80 SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by Immunoassay
....13.81 SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood
....13.82 SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood
....13.83 SARS-coV-2 (COVID19) whole genome [Nucleiotide sequence] in Isolate by Sequencing
....13.84 SARS-CoV + SARS-Cov-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay
....13.85 SARS-like coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection
....13.86 SARS-like coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....13.87 SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
....13.88 SARS-CoV-2 (COVID19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
....13.89 SARS-CoV-2 (COVID19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
....13.90 SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence
....13.91 SARS-CoV-2 (COVID19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
....13.92 SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
....13.93 SARS-CoV-2 (COVID19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay
....13.94 SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
....13.95 SARS-CoV-2 (COVID19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
....13.96 SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
....13.97 SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma Qualitative by Rapid immunoassay
....13.98 SARS-CoV-2 (COVID19) IgG and IgM panel - Serum or Plasma by Immunoassay
....13.99 SARS-CoV-2 (COVID19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
....13.100 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
....13.101 SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Immunoassay
....13.102 SARS-CoV-2 (COVID19) IgM Ab [Presence] in Serum or Plasma by Rapid immunoassay
....13.103 SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence
....13.104 SARS-CoV-2 (COVID19) Ab [Interpretation] in Serum or Plasma
....13.105 SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT
....13.106 SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT
....13.107 SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
....13.108 SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
....13.109 SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
....13.110 SARS-CoV-2 (COVID19) E gene [Presence] in Unspecified specimen by NAA with probe detection
....13.111 SARS-CoV-2 (COVID19) E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....13.112 SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection
....13.113 SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection
....13.114 SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection
....13.115 SARS-CoV-2 (COVID19) N gene [Presence] in Respiratory specimen by NAA with probe detection
....13.116 SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection
....13.117 SARS-CoV-2 (COVID19) N gene [Presence] in Unspecified specimen by NAA with probe detection
....13.118 SARS-CoV-2 (COVID19) N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....13.119 SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....13.120 SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection
....13.121 SARS-CoV-2 (COVID19) ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection
....13.122 SARS-CoV-2 (COVID19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
....13.123 SARS-CoV-2 (COVID19) RNA panel - Respiratory specimen by NAA with probe detection
....13.124 SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection
....13.125 SARS-CoV-2 (COVID19) RNA [Presence] in Nasopharynx by NAA with non-probe detection
....13.126 SARS-CoV-2 (COVID19) RNA [Presence] in Respiratory specimen by NAA with probe detection
....13.127 SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection
....13.128 SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing
....13.129 SARS-CoV-2 (COVID19) RNA [Presence] in Serum or Plasma by NAA with probe detection
....13.130 SARS-CoV-2 (COVID19) RNA [Presence] in Unspecified specimen by NAA with probe detection
....13.131 SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection
....13.132 SARS-CoV-2 (COVID19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection
....13.133 SARS-CoV-2 (COVID19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection
....13.134 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection
....13.135 SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection
....13.136 SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
....13.137 SARS-CoV-2 (COVID19) RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....13.138 SARS-CoV-2 (COVID19) S gene [Presence] in Respiratory specimen by NAA with probe detection
....13.139 SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing
....13.140 SARS-CoV-2 (COVID19) S gene [Presence] in Unspecified specimen by NAA with probe detection
....13.141 SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
....13.142 SARS-CoV-2 (COVID19) S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
....13.143 SARS CoV-2 stimulated gamma interferon [Presence] in Blood
....13.144 SARS CoV-2 stimulated gamma interferon panel - Blood
....13.145 SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection
....13.146 SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection
....13.147 SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection
....13.148 SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection
....13.149 SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection
....13.150 Travel History
....13.151 COVID-19 Underlying Condition Code
....13.152 COVID-19 Underlying Condition Reference
....13.153 Certainty of Absence
....13.154 Certainty of Presence
....13.155 Procedure Code
....13.156 Reporting Priority
....13.157 Antibody Not Detected, Past/Recent Infection LOINC answer value set.
....13.158 COVID-19 cardiovascular underlying condition reference set
....13.159 COVID-19 Disease Severity Value Set
....13.160 COVID-19 ICD 10 Diagnosis Value Set
....13.161 COVID-19 SNOMED CT Diagnosis Value Set
....13.162 COVID-19 Signs and Symptoms Severity Value Set
....13.163 COVID-19 Signs and Symptoms Value Set
....13.164 COVID-19 uncategorized underlying condition reference set
....13.165 COVID-19 gastrointestinal or hepatic underlying condition reference set
....13.166 COVID-19 hemoglobinopathy underlying condition reference set
....13.167 COVID-19 immune underlying condition reference set
....13.168 COVID-19 immunocompromised underlying condition reference set
....13.169 COVID-19 Underlying Medical Condition Value Set
....13.170 COVID-19 metabolic underlying condition reference set
....13.171 COVID-19 neurologic underlying condition reference set
....13.172 COVID-19 renal underlying condition reference set
....13.173 COVID-19 respiratory underlying condition reference set
....13.174 COVID 19 CVX Code System Vaccine Codes
....13.175 Certainty of Absence Value Set
....13.176 Certainty of Presence Value Set
....13.177 Close Contact Setting Value Set
....13.178 Detected, Not Detected, Inconclusive Value Set
....13.179 Detected, Not-detected, Equivocal, Invalid value set
....13.180 Detected, Not-detected Value Set
....13.181 Detected, Not-detected, Inconclusive, Invalid value set
....13.182 Detected, Not-detected value set
....13.183 Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set
....13.184 Influenza A, Influenza B, and SARS CoV2 value set
....13.185 Healthcare Occupation Value Set
....13.186 ISO Code System 3166 country codes
....13.187 ISO Code System 3166 state/province codes.
....13.188 Known Exposure LOINC Answer Value Set
....13.189 Positive/Negative Value Set
....13.190 COVID19 Positive, Negative, Indeterminate value set
....13.191 COVID19 Positive Negative Invalid value set
....13.192 COVID19 Positive Negative Suspected Invalid value set
....13.193 Positive, Negative value set
....13.194 Pregnancy Status Value Set
....13.195 Present, Absent, Unknown Value Set
....13.196 Reactive - Non-reactive value set
....13.197 COVID19 Reactive, Non-reactive, Invalid value set
....13.198 COVID19 Reactive Non-reactive value set
....13.199 Reporting Priorities Value Set
....13.200 Smoking Status Value Set
....13.201 State Codes Value Set
....13.202 Yes/No Value Set
....13.203 COVID19 Undefined Lab Values code system
....13.204 COVID19 Underlying Condition Category Code System